Keith J Benkov
Overview
Explore the profile of Keith J Benkov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adler J, Galanko J, Ammoury R, Benkov K, Bousvaros A, Boyle B, et al.
Am J Gastroenterol
. 2024 Oct;
PMID: 39423015
Objectives: HLA DQA1*05 has been associated with the development of anti-drug antibodies (ADA) to tumor necrosis factor antagonists (anti-TNF) and treatment failure among adults with Crohn's disease (CD). However, findings...
2.
Moses J, Adler J, Saeed S, Firestine A, Galanko J, Ammoury R, et al.
Inflamm Bowel Dis
. 2024 Oct;
PMID: 39418336
Background: Higher drug levels and combination therapy with low-dose oral methotrexate (LD-MTX) may reduce anti-tumor necrosis factor (TNF) treatment failure in pediatric Crohn's disease. We sought to (1) evaluate whether...
3.
High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease
Ebach D, Jester T, Galanko J, Firestine A, Ammoury R, Cabrera J, et al.
Am J Gastroenterol
. 2024 Mar;
119(6):1110-1116.
PMID: 38445644
Introduction: Obesity is common among patients with pediatric Crohn's disease (PCD). Some adult studies suggest obese patients respond less well to anti-tumor necrosis factor (TNF) treatment. This study sought compares...
4.
Hunter T, Komocsar W, Colletti R, Liu C, Benkov K, Dotson J, et al.
Curr Med Res Opin
. 2022 Oct;
39(1):63-69.
PMID: 36263735
Objectives: To assess treatment patterns and initial and maintenance dosing of biologics over 3 years in pediatric patients with ulcerative colitis (UC) or Crohn's disease (CD), utilizing data from the...
5.
Sauer C, Robson J, Turmelle Y, Cerezo C, Loomes K, Huang J, et al.
J Pediatr Gastroenterol Nutr
. 2020 Mar;
71(1):136-143.
PMID: 32187140
Quality training in pediatric gastroenterology, hepatology, and nutrition is essential for the future of our specialty from advancing the science through research to providing clinical care for children with gastrointestinal,...
6.
Pratt J, Jeffers D, King E, Kappelman M, Collins J, Margolis P, et al.
EGEMS (Wash DC)
. 2019 Oct;
7(1):51.
PMID: 31646151
Objective: To implement a quality improvement based system to measure and improve data quality in an observational clinical registry to support a Learning Healthcare System. Data Source: ImproveCareNow Network registry,...
7.
Lega S, Phan B, Rosenthal C, Gordon J, Haddad N, Pittman N, et al.
Inflamm Bowel Dis
. 2018 Jun;
25(1):134-141.
PMID: 29868777
Background: Infliximab (IFX) discontinuation is not uncommon during the first year of treatment due to inadequate drug concentrations and anti-IFX antibodies (ATI). Both combination therapy and proactive therapeutic drug monitoring...
8.
Reigada L, Satpute A, Hoogendoorn C, Cohen B, Lai J, Bao R, et al.
Inflamm Bowel Dis
. 2016 Aug;
22(9):2127-33.
PMID: 27482980
Background: Anxiety is linked with adverse health-related outcomes and increased health-seeking behaviors among patients with chronic illness. Yet, this relationship has received little attention in pediatric inflammatory bowel disease. The...
9.
Reigada L, Hoogendoorn C, Walsh L, Lai J, Szigethy E, Cohen B, et al.
J Pediatr Gastroenterol Nutr
. 2014 Sep;
60(1):30-5.
PMID: 25187105
Objectives: Children and adolescents diagnosed as having Crohn disease (CD), a type of inflammatory bowel disease (IBD), have increased vulnerability for anxiety symptoms that may be related to disease-related processes....
10.
Reigada L, Benkov K, Bruzzese J, Hoogendoorn C, Szigethy E, Briggie A, et al.
J Spec Pediatr Nurs
. 2013 Apr;
18(2):133-43.
PMID: 23560585
Purpose: To examine the feasibility and preliminary benefits of an integrative cognitive behavioral therapy (CBT) with adolescents with inflammatory bowel disease and anxiety. Design And Methods: Nine adolescents participated in...